[Influence of the mode of administration on the therapeutic efficacy of Clenbuterol, a new bronchospasmolytic agent (author's transl)].
D000814:Aniline Compounds / Q000008:administration & dosage / Q000627:therapeutic use; D001986:Bronchial Spasm / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D004341:Drug Evaluation; D004983:Ethanolamines / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D009921:Metaproterenol / Q000627:therapeutic use
D000814:Aniline Compounds; D001993:Bronchodilator Agents; D004983:Ethanolamines; D009921:Metaproterenol
Vergleichsprüfung verschiedener Anwendungsformen von Clenbuterol, einer neuen bronchialerweiternden Substanz